Skip to main content

Tevogen Inc.

For the period ended Apr 30, 2025. Filed Apr 30, 2025.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Apr 30, 2025 · Filed Apr 30, 2025

TVGN$5.59+0.5%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Cover page

Show cover page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

(Amendment No. )

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐Preliminary Proxy Statement
☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☒Definitive Proxy Statement
☐Definitive Additional Materials
☐Soliciting Material under §240.14a-12

Tevogen Bio Holdings Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

☒No fee required
☐Fee paid previously with preliminary materials
☐Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

TEVOGEN BIO HOLDINGS INC.

**15 Independence Boulevard, Suite #410

Warren, New Jersey

NOTICE OF 2025 ANNUAL MEETING OF STOCKHOLDERS

TO BE HELD AT 11 A.M. EASTERN TIME ON JUNE 23, 2025

MEETING LOCATION:

www.virtualshareholdermeeting.com/TVGN2025

Dear Tevogen Bio Holdings Inc. Stockholder:

You are cordially invited to attend the 2025 Annual Meeting of the Stockholders (the “Annual Meeting”) of Tevogen Bio Holdings Inc. (the “Company”). The Annual Meeting will be held on June 23, 2025, commencing at 11:00 a.m. Eastern Time, and will be a completely virtual meeting of stockholders.

The items of business for the Annual Meeting are to:

1.Elect as Class I directors the two nominees named in the attached proxy statement to serve for a term of three years each, or until their respective successors are duly elected and qualified.

The Board of Directors recommends that you voteFOR the election of each director nominee.

2.Ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.

The Board of Directors recommends that you voteFOR Proposal 2.

We will also transact any other business as may properly come before the meeting or any adjournment or postponement thereof.

The Annual Meeting will be held only via live webcast. We believe that the virtual meeting format expands stockholder access and participation and improves communications.

You will be able to attend and participate in the Annual Meeting online, vote your shares electronically, and submit your questions prior to and during the meeting by visiting:www.virtualshareholdermeeting.com/TVGN2025. To vote at the meeting, you must have your control number that is shown on your Notice of Internet Availability of Proxy Materials (“Notice”), voting instruction form, or proxy card. We encourage you to access the Annual Meeting prior to the start time to allow ample time for online check-in. The website will be open for check-in beginning at 10:45 a.m. Eastern Time on the date of the Annual Meeting.

Only stockholders of record at the close of business on April 30, 2025 are entitled to notice of and to vote at the Annual Meeting. Any person who was not a stockholder as of the record date may attend the Annual Meeting as an observer but will not be able to vote or ask questions.

We encourage you to attend the Annual Meeting, but it is important that your shares are represented at the Annual Meeting whether or not you plan to attend. To ensure that you will be represented, we ask you to vote online, by mail, or by phone as soon as possible, using one of the methods below.

We expect to commence mailing these proxy materials to our security holders on or about April 30, 2025.

Your Vote is Important

We encourage all stockholders of record to read the attached proxy statement with care and vote right away using any of the following methods, even if they intend to attend the Annual Meeting. If you plan to vote during the Annual Meeting, you may do so if you enter your “control number.” The control number is a 16-digit number that you can find in your Notice (if you received the proxy materials via electronic delivery), voting instruction form (if you are a beneficial owner who received proxy materials by mail), or proxy card (if you are a stockholder of record who received proxy materials by mail), as applicable, at the time you log into the meeting atwww.virtualshareholdermeeting.com/TVGN2025. Please note, however, that if your shares are held of record by a broker, bank, or other nominee and you wish to vote at the meeting, you may need to obtain a proxy issued in your name from that record holder. Please contact your broker, bank, or other nominee for information about specific requirements if you would like to vote your shares at the meeting.

To vote online atwww.proxyvote.com, have the 16-digit control number available and then follow the instructions. Beneficial owners who do not have a control number should follow the instructions provided on the voting instruction card or otherwise provided by your bank, broker or other nominee.

Onlinewww.proxyvote.com
By PhoneIn the U.S. or Canada dial toll-free (800) 690-6903
By MailCast your ballot, sign your proxy card, and send in our prepaid envelope

Tevogen Bio Holdings Inc.

By order of the Board of Directors,

Dr. Ryan Saadi

Chairperson of the Board of Directors, Director, and Chief Executive Officer

Warren, New Jersey, USA

April 30, 2025

Table of Contents

Cautionary Note Regarding Forward-Looking Statements1
Proxy Summary2
About Tevogen2
Voting Matters and Board Recommendations2
How to Vote2
Proposal No. 1 - Election of Directors3
Board of Directors3
Directors and Nominees3
Corporate Governance6
Composition of the Board6
Director Qualifications6
Director Independence6
Board Leadership Structure6
Role of Board in Risk Oversight7
Controlled Company Status7
Board Meetings and Committees7
Nomination of Directors9
Code of Business Conduct and Ethics9
Insider Trading Policy10
Communications with the Board of Directors10
Certain Relationships and Related Person Transactions10
Security Ownership of Certain Beneficial Owners and Management15
Director Compensation16
Executive Compensation17
Summary Compensation Table17
Narrative Disclosure to Summary Compensation Table17
2025 Executive Compensation Program18
Outstanding Equity Awards at Fiscal Year-End19
Anti-Hedging and Anti-Pledging Policy19
Policies and Practices Related to the Grant of Certain Equity Awards19
Equity Compensation Plan Information19
Delinquent Section 16(a) Reports19
Proposal No. 2 - Ratification of Appointment of Independent Registered Public Accounting Firm20
Change in Our Independent Registered Public Accounting Firm20
Audit Fees20
Pre-Approval Policies and Procedures20
Audit Committee Report21
Questions and Answers22
Additional Information27
Stockholder Proposals to be Included in Next Year’s Proxy Statement27
Stockholder Nominations and Proposals to be Brought Before Next Year’s Annual Meeting27
Householding27
Other Business27
Availability of Proxy Materials27

i

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.